Murine Malaria Model: Ketoconazole Prevented Malaria while Proguanil and Sulfadoxine/Pyrimethamine Protected against Malaria-associated Anemia and Kidney Damage
- 1 March 2024
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Infectious Disorders - Drug Targets
- Vol. 24 (2) , 1-13
Abstract
Background:: The concern about the global spread of resistant malaria has made the researchers not focus only on the treatment of established infections but relatively more on the prevention of the disease. Objective:: This study evaluates the chemopreventive activity of ketoconazole in a murine malarial model. Method:: Five out of seven groups of mice were pretreated for five days with proguanil (PRG), sulfadoxine/ pyrimethamine (SP), 10, 20, and 40 mg/kg body weight (b.w) of ketoconazole (KET10, KET20, and KET40), before being infected (on the sixth day) with Plasmodium berghei. Two other groups were infected-not-treated (INT) and not-infected-nor-treated (NINT). At 72 hours postinfection, five out of ten mice in each group were sacrificed to assess parasitemia, chemoprevention, hematologic, hepatic, and renal parameters. The remaining mice were observed for 28 days to determine their mean survival day post-infection (SDPI). Results:: All ketoconazole groups, except KET10, demonstrated 100% chemoprevention and significantly higher mean SDPI (p<0.001) in relation to INT (negative control). There was no significant difference in the mean SDPI observed in KET20 in relation to PRG or NINT (healthy control). A dose-related increase (p<0.01) in the mean plasma urea was observed when ketoconazole groups were compared to one another: KET10 versus KET20 (p<0.01) and KET20 versus KET40 (p<0.01). Sulfadoxine/pyrimethamine demonstrated significantly reduced mean plasma urea (p<0.001) and creatinine (p<0.05) in relation to INT and NINT, respectively. While PRG demonstrated significantly higher mean red blood cell (RBC), hemoglobin (HGB), and hematocrit (HCT) in relation to INT. Conclusion:: Ketoconazole possesses prophylactic antimalarial activity with associated dose-related renal impairment. Sulfadoxine/pyrimethamine demonstrated renoprotective potentials, while PRG prevented malaria-associated anemia.Keywords
This publication has 93 references indexed in Scilit:
- Renoprotective effects of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via suppressing NF-κB signaling and NLRP3 inflammasome activation by exosomes in ratsBiochemical Pharmacology, 2019
- Malaria Vaccines: Recent Advances and New HorizonsCell Host & Microbe, 2018
- Prevention Efforts for MalariaCurrent Tropical Medicine Reports, 2018
- Pretreatment albumin to globulin ratio can serve as a prognostic marker in human cancers: a meta-analysisClinica Chimica Acta, 2018
- Arteether resistance reversal by ketoconazole/fluconazole in rodent malaria parasite Plasmodium vinckeiParasitology Research, 2015
- Ketoconazole, a cytochrome P450 inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensisActa Tropica, 2013
- Intermittent preventive treatment for malaria in children living in areas with seasonal transmissionCochrane Database of Systematic Reviews, 2012
- Epidemiology, pathophysiology, management and outcome of renal dysfunction associated with plasmodia infectionParasitology Research, 2007
- Antimalarial prophylaxis in pregnant Nigerian womenThe Lancet, 1990
- Hepatic reactions during ketoconazole treatmentThe American Journal of Medicine, 1983